Development of a MicroRNA Signature Predictive of Recurrence and Survival in Pancreatic Ductal Adenocarcinoma

Development of a MicroRNA Signature Predictive of Recurrence and Survival in Pancreatic Ductal Adenocarcinoma

Background: Optimal patient selection for radiotherapy in pancreatic ductal adenocarcinoma (PDAC) is unestablished. Molecular profiling may select patients at high risk for locoregional recurrence (LRR) who would benefit from radiation. Methods: We included resectable pancreatic cancer (R-PDAC) pati...

Full description

Bibliographic Details
Main Authors: Nikhil T. Sebastian, Amy Webb, Kenneth W. Merrell, Eugene J. Koay, Adam R. Wolfe, Lizhi Zhang, Tyler J. Wilhite, Dalia Elganainy, Ryan Robb, Wei Chen, Jordan Cloyd, Mary Dillhoff, Allan Tsung, Laith Abushahin, Anne Noonan, Terence M. Williams
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Cancers
Subjects:
pancreatic cancer
microRNA
locoregional recurrence
local recurrence
adjuvant radiation
neoadjuvant radiation
Online Access:https://www.mdpi.com/2072-6694/13/20/5168

Internet

https://www.mdpi.com/2072-6694/13/20/5168

Similar Items